GSEA showed that hallmark oxidative phosphorylation, adipogenesis, hedgehog signaling and MYC target V1 were significantly enriched in glioma patients in the low m6A group (Table 3; Figures 5C–H). This evidence concerns the gene MYC and central nervous system cancer.